BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26014457)

  • 1. Hepatitis B Virus Immunization Before and After Pediatric Liver Transplantation: Check, Catch-Up, and Check Again!
    L'Huillier AG; McLin VA; Posfay-Barbe KM
    Am J Transplant; 2015 Aug; 15(8):2275-6. PubMed ID: 26014457
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to L'Huillier et al.
    Leung DH; Ton-That M; Economides JM; Healy CM
    Am J Transplant; 2015 Aug; 15(8):2277. PubMed ID: 26014288
    [No Abstract]   [Full Text] [Related]  

  • 3. High prevalence of hepatitis B nonimmunity in vaccinated pediatric liver transplant recipients.
    Leung DH; Ton-That M; Economides JM; Healy CM
    Am J Transplant; 2015 Feb; 15(2):535-40. PubMed ID: 25611886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The questionable role of immunization against hepatitis B in HBV infected liver transplant patients.
    Samuel D; Shouval D
    J Hepatol; 2005 Aug; 43(2):203-6. PubMed ID: 15975686
    [No Abstract]   [Full Text] [Related]  

  • 5. Active immunization for prevention of De novo hepatitis B virus infection after adult living donor liver transplantation with a hepatitis B core antigen-positive graft.
    Wang SH; Loh PY; Lin TL; Lin LM; Li WF; Lin YH; Lin CC; Chen CL
    Liver Transpl; 2017 Oct; 23(10):1266-1272. PubMed ID: 28691231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B vaccination among the Nicobarese tribe: Need to document the impact.
    Murhekar M
    Indian J Med Res; 2015 May; 141(5):662. PubMed ID: 26139786
    [No Abstract]   [Full Text] [Related]  

  • 7. Epidemiology and prevention of hepatitis B virus infection.
    Kwon SY; Lee CH
    Korean J Hepatol; 2011 Jun; 17(2):87-95. PubMed ID: 21757978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel strategies in vaccine design: can nanocapsules help prevent and treat hepatitis B?
    Gehring S; Pietrzak-Nguyen A; Fichter M; Landfester K
    Nanomedicine (Lond); 2017 Jun; 12(11):1205-1207. PubMed ID: 28517963
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis B and C serologic profiles of Canadian organ donors and recipients: retrospective 10-year review at a single center.
    Burton CE; Doucette KE; Mabilangan CA; Plitt SS; Lee BE; Preiksaitis JK
    Transpl Infect Dis; 2016 Aug; 18(4):520-8. PubMed ID: 27226204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The first identified hepatitis B virus vaccine escape mutation in Turkey.
    Kutlu T; Soycan LY; Karatayli E; Türkyilmaz AR; Yurdaydin C; Bozdayi AM
    J Clin Virol; 2006 Feb; 35(2):201-2. PubMed ID: 16230046
    [No Abstract]   [Full Text] [Related]  

  • 11. An Experiment of Nature: HBV-naive Recipients Receiving Liver Grafts With HBV Core Antibody-positive Donors Without Antiviral Prophylaxis.
    Fallahzadeh MA; Trotter JF
    Transplantation; 2020 Aug; 104(8):e245-e246. PubMed ID: 32732858
    [No Abstract]   [Full Text] [Related]  

  • 12. The global impact of vaccination against hepatitis B: a historical overview.
    Zanetti AR; Van Damme P; Shouval D
    Vaccine; 2008 Nov; 26(49):6266-73. PubMed ID: 18848855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of emergence of hepatitis B virus escape variants: approaches to prevention.
    Thomas HC
    J Viral Hepat; 1998 Nov; 5 Suppl 2():31-6. PubMed ID: 9857358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined immunization against hepatitis B: five-year follow-up.
    Rodgers A
    Pediatr Infect Dis J; 1993 Nov; 12(11):968. PubMed ID: 8265299
    [No Abstract]   [Full Text] [Related]  

  • 15. [Persistence of immunity after hepatitis B vaccination].
    Madaliński K
    Przegl Epidemiol; 2002; 56(4):605-13. PubMed ID: 12666586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preadolescent non- and hyporesponders following three doses of hepatitis B vaccine need only one more dose.
    Duval B; Boulianne N; De Serres G; De Wals P; Massé R; Trudeau G
    Vaccine; 2002 Nov; 20(31-32):3632-4. PubMed ID: 12399188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term protection against hepatitis B in pediatric liver recipients can be achieved effectively with vaccination after transplantation.
    Kwon CH; Suh KS; Yi NJ; Chang SH; Cho YB; Cho JY; Lee HJ; Seo JK; Lee KU
    Pediatr Transplant; 2006 Jun; 10(4):479-86. PubMed ID: 16712607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of hepatitis B-antibody loss and a case report of
    Sintusek P; Posuwan N; Wanawongsawad P; Jitraruch S; Poovorawan Y; Chongsrisawat V
    World J Gastroenterol; 2018 Feb; 24(6):752-762. PubMed ID: 29456414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of de novo hepatitis B with adefovir plus vaccination in recipients of liver transplants from core antibody-positive donors.
    Chang MS; Olsen SK; Pichardo EM; Heese S; Stiles JB; Guarrera JV; Emond JC; Brown RS
    Liver Transpl; 2013 Apr; 19(4):462. PubMed ID: 23536483
    [No Abstract]   [Full Text] [Related]  

  • 20. Facing the challenges of hepatitis B management in a developing country.
    Oluyemi A; Odeghe E
    J Infect Dev Ctries; 2012 Mar; 6(3):299-300. PubMed ID: 22421615
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.